L'Oreal Completes Acquisition of Lactobio
By Andrea Figueras
L'Oreal has completed the acquisition of the Danish probiotic and microbiome research company Lactobio for an undisclosed amount.
The French beauty company said Monday that the move aims to boost its microbiome research efforts dedicated to beauty and strengthen its position in this particular scientific territory, the company said.
"The strategic acquisition builds on 20 years of advanced research by L'Oreal into the microbiome scientific territory," it said.
L'Oreal will be able to benefit from Lactobio's microbiome expertise and portfolio to develop topical formulations and new cosmetic solutions using live bacteria, the company said.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
December 04, 2023 13:04 ET (18:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations